Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4D | Q08499 | 2/20 | 1.00 |
| ▸ | OPRK1 | P41145 | 2/20 | 1.00 |
| ▸ | CNR1 | P21554 | 1/20 | 1.00 |
| ▸ | NTSR1 | P30989 | 1/20 | 1.00 |
| ▸ | GABRA1 | P14867 | 5/20 | 0.74 |
| ▸ | GABRA5 | P31644 | 5/20 | 0.74 |
| ▸ | GABRA3 | P34903 | 5/20 | 0.74 |
| ▸ | GABRA2 | P47869 | 5/20 | 0.74 |
| ▸ | GABRB2 | P47870 | 5/20 | 0.74 |
| ▸ | GABRG2 | P18507 | 4/20 | 0.74 |
| ▸ | GABRB3 | P28472 | 4/20 | 0.74 |
| ▸ | GABRP | O00591 | 3/20 | 0.74 |
| ▸ | GABRD | O14764 | 3/20 | 0.74 |
| ▸ | GABRB1 | P18505 | 3/20 | 0.74 |
| ▸ | GABRA4 | P48169 | 3/20 | 0.74 |
| ▸ | GABRE | P78334 | 3/20 | 0.74 |
| ▸ | GABRA6 | Q16445 | 3/20 | 0.74 |
| ▸ | GABRG1 | Q8N1C3 | 3/20 | 0.74 |
| ▸ | GABRG3 | Q99928 | 3/20 | 0.74 |
| ▸ | GABRQ | Q9UN88 | 3/20 | 0.74 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Nordazepam SCHEMBL29354494 | 1.00 | PDE4D (1.00) | PDE4DOPRK1CNR1NTSR1GABRA1 | |
| Nordazepam SCHEMBL8090999 | 1.00 | PDE4D (1.00) | PDE4DOPRK1CNR1NTSR1GABRA1 | |
| Nordazepam SCHEMBL31000330 | 1.00 | PDE4D (1.00) | PDE4DOPRK1CNR1NTSR1GABRA1 | |
| Oxazepam SCHEMBL6680438 | 0.88 | LMNA (0.81) | PDE4DOPRK1CNR1NTSR1GABRA1 | |
| Diazepam SCHEMBL8931438 | 0.87 | GABRA1 (0.79) | PDE4DOPRK1CNR1NTSR1GABRA1 | |
| Diazepam SCHEMBL6823824 | 0.87 | GABRA1 (0.79) | PDE4DOPRK1CNR1NTSR1GABRA1 | |
| SCHEMBL10149934 | 0.86 | PDE4D (0.76) | PDE4DOPRK1CNR1NTSR1GABRA1 | |
| SCHEMBL4371914 | 0.85 | PDE4D (0.74) | PDE4DOPRK1CNR1NTSR1GABRA1 | |
| SCHEMBL4373660 | 0.85 | PDE4D (0.74) | PDE4DOPRK1CNR1NTSR1GABRA1 | |
| Delorazepam SCHEMBL32681132 | 0.85 | GABRA1 (1.00) | PDE4DOPRK1CNR1NTSR1GABRA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4757 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3436000-B1 | USE OF CANNABINOIDS IN THE TREATMENT OF STURGE WEBER SYNDROME | JAZZ PHARMACEUTICALS RESEARCH UK LTD (GB) | 2025-07-16 | — | — | EP | claimed |
| US-20250179064-A1 | BENZOQUINOLONE INHIBITORS OF VMAT2 | AUSPEX PHARMACEUTICALS LLC | 2025-06-05 | — | — | US | claimed |
| US-20250152591-A1 | TREATMENT OF HEMATOLOGICAL MALIGNANCIES WITH MENIN INHIBITORS AND P-GLYCOPROTEIN INHIBITORS | KURA ONCOLOGY INC (US) | 2025-05-15 | — | — | US | claimed |
| EP-3592350-B1 | PHARMACEUTICAL COMPOSITIONS COMPRISING METYRAPONE AND OXAZEPAM AND USES THEREOF | EMBERA NEUROTHERAPEUTICS INC (US) | 2025-03-05 | — | — | EP | claimed |
| EP-4472637-A1 | TREATMENT OF HEMATOLOGICAL MALIGNANCIES WITH MENIN INHIBITORS AND P-GLYCOPROTEIN INHIBITORS | Kura Oncology, Inc. (US) | 2024-12-11 | — | — | EP | claimed |
| US-12133922-B2 | Abuse resistant capsule | R.P. SCHERER TECHNOLOGIES, LLC (US) | 2024-11-05 | — | — | US | claimed |
| US-20240353434-A1 | METHOD FOR SIMULTANEOUS AND EFFICIENT DETECTION OF RESIDUES OF 36 ANTIDEPRESSANTS IN SLUDGES | Institute of Microbiology, Guangdong Academy of Sciences (Guangdong Detection Center of Microbiology (CN) | 2024-10-24 | — | — | US | claimed |
| US-20240350428-A1 | USE OF CANNABINOIDS IN THE TREATMENT OF EPILEPSY | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE | 2024-10-24 | — | — | US | claimed |
| CN-118773221-A | CYP2C19 gene mutant nucleic acid segment and application thereof | 中南大学湘雅三医院 | 2024-10-15 | — | — | CN | claimed |
| EP-4422607-A1 | ORAL AND NASAL COMPOSITIONS AND METHODS OF TREATMENT | Aquestive Therapeutics, Inc. (US) | 2024-09-04 | — | — | EP | claimed |
| WO-2002006826-A1 | SINGLE-PATIENT DRUG TRIALS USED WITH ACCUMULATED DATABASE | OPT-E-SCRIP, INC. (US) | 2002-01-24 | — | — | WO | claimed |
| WO-2002000221-A1 | ENHANCED BRAIN FUNCTION BY GABA-ERGIC STIMULATION | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2002-01-03 | — | — | WO | claimed |
| CN-1294519-A | Pharmaceutical composition containing a compound having an activity of promoting the absorption of an active ingredient | INPHARMA SA (CH) | 2001-05-09 | — | — | CN | claimed |
| EP-1073470-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2001-02-07 | — | — | EP | claimed |
| EP-1067942-A1 | HIGH-ENERGY CYCLODEXTRIN COMPLEXES | Cyclops, EHF. (IS) | 2001-01-17 | — | — | EP | claimed |
| WO-2000048636-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2000-08-24 | — | — | WO | claimed |
| WO-1999061014-A2 | COMPOSITIONS AND METHODS EMPLOYING R(-) FLUOXETINE AND OTHER ACTIVE INGREDIENTS | SEPRACOR INC. (US) | 1999-12-02 | — | — | WO | claimed |
| WO-1999042111-A1 | HIGH-ENERGY CYCLODEXTRIN COMPLEXES | CYCLOPS, EHF. (IS) | 1999-08-26 | — | — | WO | claimed |
| US-5308768-A | Detection of cortisols, cortisone and corticosterone | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 1994-05-03 | — | — | US | claimed |
| US-4557934-A | ALONG WITH A DIOL PYRROLIDONE OR AN AZACYCLOPENTAN-2-ONE | THE PROCTER & GAMBLE COMPANY (US) | 1985-12-10 | — | — | US | claimed |